Ming-Hao Xu (Minghao Xu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Dendritic Cells

Long Non Coding Rna

Top Venues

Cancer research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer research 84 (11) (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy. Cancer research (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer research 84 (11) (2024)
Ming-Hao Xu, Cheng Huang, Mei-Ling Li, Xiao-Dong Zhu, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun, Ying-Hao Shen
Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study. Cancer medicine (2023)